Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Parkinson's Disease

  Free Subscription


06.08.2018

1 Brain Res
1 J Neurol Neurosurg Psychiatry
1 Lancet Neurol
6 Neurology
1 Neurosci Lett
2 PLoS One
1 Rev Neurol (Paris)


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Brain Res

  1. MAMAIS A, Manzoni C, Nazish I, Arber C, et al
    Analysis of macroautophagy related proteins in G2019S LRRK2 Parkinson's disease brains with Lewy Body pathology.
    Brain Res. 2018 Jul 25. pii: S0006-8993(18)30407.
    PubMed     Text format     Abstract available


    J Neurol Neurosurg Psychiatry

  2. VILAS D, Gelpi E, Aldecoa I, Grau O, et al
    Lack of central and peripheral nervous system synuclein pathology in R1441G LRRK2-associated Parkinson's disease.
    J Neurol Neurosurg Psychiatry. 2018 Jul 27. pii: jnnp-2018-318473.
    PubMed     Text format    


    Lancet Neurol

  3. KATZENSCHLAGER R, Poewe W, Rascol O, Trenkwalder C, et al
    Apomorphine subcutaneous infusion in patients with Parkinson's disease with persistent motor fluctuations (TOLEDO): a multicentre, double-blind, randomised, placebo-controlled trial.
    Lancet Neurol. 2018 Jul 25. pii: S1474-4422(18)30239.
    PubMed     Text format     Abstract available


    Neurology

  4. KARAM C, Galetta S
    Editors' note: Clinical outcomes of asleep vs awake deep brain stimulation for Parkinson disease.
    Neurology. 2018;91:239.
    PubMed     Text format    

  5. SIDIROPOULOS C
    Reader response: Clinical outcomes of asleep vs awake deep brain stimulation for Parkinson disease.
    Neurology. 2018;91:239-240.
    PubMed     Text format    

  6. AZIZ TZ
    Editorialist response: Clinical outcomes of asleep vs awake deep brain stimulation for Parkinson disease.
    Neurology. 2018;91:240.
    PubMed     Text format    

  7. TROSTER AI
    Reader response: Clinical outcomes of asleep vs awake deep brain stimulation for Parkinson disease.
    Neurology. 2018;91:240-241.
    PubMed     Text format    

  8. BRODSKY MA
    Author response: Clinical outcomes of asleep vs awake deep brain stimulation for Parkinson disease.
    Neurology. 2018;91:241-242.
    PubMed     Text format    

  9. KARCESKI S
    Does deep brain stimulation help early or mild Parkinson disease?
    Neurology. 2018;91:e495-e497.
    PubMed     Text format    


    Neurosci Lett

  10. LI D, Song X, Huang H, Huang H, et al
    Association of Parkinson's disease-related pain with plasma interleukin-1, interleukin-6, interleukin-10, and tumour necrosis factor-alpha.
    Neurosci Lett. 2018 Jul 28. pii: S0304-3940(18)30500.
    PubMed     Text format     Abstract available


    PLoS One

  11. BEYLE A, Glonnegger H, Cerff B, Graber S, et al
    The Multiple Object Test as a performance-based tool to assess the decline of ADL function in Parkinson's disease.
    PLoS One. 2018;13:e0200990.
    PubMed     Text format     Abstract available

  12. CHOI MG, Kim MJ, Kim DG, Yu R, et al
    Sequestration of synaptic proteins by alpha-synuclein aggregates leading to neurotoxicity is inhibited by small peptide.
    PLoS One. 2018;13:e0195339.
    PubMed     Text format     Abstract available


    Rev Neurol (Paris)

  13. DE VERDAL M, Renard D, Collombier L, Castelnovo G, et al
    123I-FP-CIT SPECT imaging in blepharospasm.
    Rev Neurol (Paris). 2017 Jun 16. pii: S0035-3787(16)30061.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Parkinson's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: